Breast Cancer: Drugs
Commons · Question 114336 · Tabled 20 Feb 2026 · Department of Health and Social Care · Official record
Answered 3 Mar 2026
Question
Asked by Steve Darling
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of NICE condition severity ratings on the accessibility of drugs for those with secondary breast cancer.
Answer
Answered by Stephen Kinnock, 3 Mar 2026
he latest data for technology appraisals published up until the end of September 2025 shows that the National Institute for Health and Care Excellence (NICE) has recommended a greater proportion of medicines for advanced cancer since the severity modifier...